世界のマールブルグウイルス感染症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Marburgvirus Infection Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3557 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、マールブルグウイルス感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・マールブルグウイルス感染症の市場動向 ・企業の競争状況、市場シェア ・マールブルグウイルス感染症の種類別市場規模（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他） ・マールブルグウイルス感染症の用途別市場規模（病院、クリニック、その他） ・マールブルグウイルス感染症の北米市場規模2016-2027（アメリカ、カナダ） ・マールブルグウイルス感染症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・マールブルグウイルス感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・マールブルグウイルス感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・マールブルグウイルス感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Arno Therapeutics Inc、BioCryst Pharmaceuticals Inc、Eisai Co Ltd、Emergent BioSolutions Inc、Fab'entech SA、Integrated BioTherapeutics Inc、Johnson & Johnson、NanoViricides Inc、Profectus BioSciences Inc、Rodos BioTarget GmbH、Sarepta Therapeutics Inc、Theravectys SA） ・結論

Market Analysis and Insights: Global Marburgvirus Infection Market
The global Marburgvirus Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Marburgvirus Infection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Marburgvirus Infection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Marburgvirus Infection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Marburgvirus Infection market.

Global Marburgvirus Infection Scope and Market Size
Marburgvirus Infection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marburgvirus Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Eritoran Tetrasodium
AR-12
ARD-5
AVI-7288
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Arno Therapeutics Inc
BioCryst Pharmaceuticals Inc
Eisai Co Ltd
Emergent BioSolutions Inc
Fab’entech SA
Integrated BioTherapeutics Inc
Johnson & Johnson
NanoViricides Inc
Profectus BioSciences Inc
Emergent BioSolutions Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marburgvirus Infection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Eritoran Tetrasodium
1.2.3 AR-12
1.2.4 ARD-5
1.2.5 AVI-7288
1.2.6 Others
1.3 Market by Application
1.3.1 Global Marburgvirus Infection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Marburgvirus Infection Market Perspective (2016-2027)
2.2 Marburgvirus Infection Growth Trends by Regions
2.2.1 Marburgvirus Infection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Marburgvirus Infection Historic Market Share by Regions (2016-2021)
2.2.3 Marburgvirus Infection Forecasted Market Size by Regions (2022-2027)
2.3 Marburgvirus Infection Industry Dynamic
2.3.1 Marburgvirus Infection Market Trends
2.3.2 Marburgvirus Infection Market Drivers
2.3.3 Marburgvirus Infection Market Challenges
2.3.4 Marburgvirus Infection Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Marburgvirus Infection Players by Revenue
3.1.1 Global Top Marburgvirus Infection Players by Revenue (2016-2021)
3.1.2 Global Marburgvirus Infection Revenue Market Share by Players (2016-2021)
3.2 Global Marburgvirus Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Marburgvirus Infection Revenue
3.4 Global Marburgvirus Infection Market Concentration Ratio
3.4.1 Global Marburgvirus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marburgvirus Infection Revenue in 2020
3.5 Marburgvirus Infection Key Players Head office and Area Served
3.6 Key Players Marburgvirus Infection Product Solution and Service
3.7 Date of Enter into Marburgvirus Infection Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Marburgvirus Infection Breakdown Data by Type
4.1 Global Marburgvirus Infection Historic Market Size by Type (2016-2021)
4.2 Global Marburgvirus Infection Forecasted Market Size by Type (2022-2027)

5 Marburgvirus Infection Breakdown Data by Application
5.1 Global Marburgvirus Infection Historic Market Size by Application (2016-2021)
5.2 Global Marburgvirus Infection Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Marburgvirus Infection Market Size (2016-2027)
6.2 North America Marburgvirus Infection Market Size by Type
6.2.1 North America Marburgvirus Infection Market Size by Type (2016-2021)
6.2.2 North America Marburgvirus Infection Market Size by Type (2022-2027)
6.2.3 North America Marburgvirus Infection Market Size by Type (2016-2027)
6.3 North America Marburgvirus Infection Market Size by Application
6.3.1 North America Marburgvirus Infection Market Size by Application (2016-2021)
6.3.2 North America Marburgvirus Infection Market Size by Application (2022-2027)
6.3.3 North America Marburgvirus Infection Market Size by Application (2016-2027)
6.4 North America Marburgvirus Infection Market Size by Country
6.4.1 North America Marburgvirus Infection Market Size by Country (2016-2021)
6.4.2 North America Marburgvirus Infection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Marburgvirus Infection Market Size (2016-2027)
7.2 Europe Marburgvirus Infection Market Size by Type
7.2.1 Europe Marburgvirus Infection Market Size by Type (2016-2021)
7.2.2 Europe Marburgvirus Infection Market Size by Type (2022-2027)
7.2.3 Europe Marburgvirus Infection Market Size by Type (2016-2027)
7.3 Europe Marburgvirus Infection Market Size by Application
7.3.1 Europe Marburgvirus Infection Market Size by Application (2016-2021)
7.3.2 Europe Marburgvirus Infection Market Size by Application (2022-2027)
7.3.3 Europe Marburgvirus Infection Market Size by Application (2016-2027)
7.4 Europe Marburgvirus Infection Market Size by Country
7.4.1 Europe Marburgvirus Infection Market Size by Country (2016-2021)
7.4.2 Europe Marburgvirus Infection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Marburgvirus Infection Market Size (2016-2027)
8.2 Asia-Pacific Marburgvirus Infection Market Size by Type
8.2.1 Asia-Pacific Marburgvirus Infection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Marburgvirus Infection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Marburgvirus Infection Market Size by Type (2016-2027)
8.3 Asia-Pacific Marburgvirus Infection Market Size by Application
8.3.1 Asia-Pacific Marburgvirus Infection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Marburgvirus Infection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Marburgvirus Infection Market Size by Application (2016-2027)
8.4 Asia-Pacific Marburgvirus Infection Market Size by Region
8.4.1 Asia-Pacific Marburgvirus Infection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Marburgvirus Infection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Marburgvirus Infection Market Size (2016-2027)
9.2 Latin America Marburgvirus Infection Market Size by Type
9.2.1 Latin America Marburgvirus Infection Market Size by Type (2016-2021)
9.2.2 Latin America Marburgvirus Infection Market Size by Type (2022-2027)
9.2.3 Latin America Marburgvirus Infection Market Size by Type (2016-2027)
9.3 Latin America Marburgvirus Infection Market Size by Application
9.3.1 Latin America Marburgvirus Infection Market Size by Application (2016-2021)
9.3.2 Latin America Marburgvirus Infection Market Size by Application (2022-2027)
9.3.3 Latin America Marburgvirus Infection Market Size by Application (2016-2027)
9.4 Latin America Marburgvirus Infection Market Size by Country
9.4.1 Latin America Marburgvirus Infection Market Size by Country (2016-2021)
9.4.2 Latin America Marburgvirus Infection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Marburgvirus Infection Market Size (2016-2027)
10.2 Middle East & Africa Marburgvirus Infection Market Size by Type
10.2.1 Middle East & Africa Marburgvirus Infection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Marburgvirus Infection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Marburgvirus Infection Market Size by Type (2016-2027)
10.3 Middle East & Africa Marburgvirus Infection Market Size by Application
10.3.1 Middle East & Africa Marburgvirus Infection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Marburgvirus Infection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Marburgvirus Infection Market Size by Application (2016-2027)
10.4 Middle East & Africa Marburgvirus Infection Market Size by Country
10.4.1 Middle East & Africa Marburgvirus Infection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Marburgvirus Infection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Arno Therapeutics Inc
11.1.1 Arno Therapeutics Inc Company Details
11.1.2 Arno Therapeutics Inc Business Overview
11.1.3 Arno Therapeutics Inc Marburgvirus Infection Introduction
11.1.4 Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.1.5 Arno Therapeutics Inc Recent Development
11.2 BioCryst Pharmaceuticals Inc
11.2.1 BioCryst Pharmaceuticals Inc Company Details
11.2.2 BioCryst Pharmaceuticals Inc Business Overview
11.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Introduction
11.2.4 BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.2.5 BioCryst Pharmaceuticals Inc Recent Development
11.3 Eisai Co Ltd
11.3.1 Eisai Co Ltd Company Details
11.3.2 Eisai Co Ltd Business Overview
11.3.3 Eisai Co Ltd Marburgvirus Infection Introduction
11.3.4 Eisai Co Ltd Revenue in Marburgvirus Infection Business (2016-2021)
11.3.5 Eisai Co Ltd Recent Development
11.4 Emergent BioSolutions Inc
11.4.1 Emergent BioSolutions Inc Company Details
11.4.2 Emergent BioSolutions Inc Business Overview
11.4.3 Emergent BioSolutions Inc Marburgvirus Infection Introduction
11.4.4 Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.4.5 Emergent BioSolutions Inc Recent Development
11.5 Fab’entech SA
11.5.1 Fab’entech SA Company Details
11.5.2 Fab’entech SA Business Overview
11.5.3 Fab’entech SA Marburgvirus Infection Introduction
11.5.4 Fab’entech SA Revenue in Marburgvirus Infection Business (2016-2021)
11.5.5 Fab’entech SA Recent Development
11.6 Integrated BioTherapeutics Inc
11.6.1 Integrated BioTherapeutics Inc Company Details
11.6.2 Integrated BioTherapeutics Inc Business Overview
11.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Introduction
11.6.4 Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.6.5 Integrated BioTherapeutics Inc Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Marburgvirus Infection Introduction
11.7.4 Johnson & Johnson Revenue in Marburgvirus Infection Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 NanoViricides Inc
11.8.1 NanoViricides Inc Company Details
11.8.2 NanoViricides Inc Business Overview
11.8.3 NanoViricides Inc Marburgvirus Infection Introduction
11.8.4 NanoViricides Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.8.5 NanoViricides Inc Recent Development
11.9 Profectus BioSciences Inc
11.9.1 Profectus BioSciences Inc Company Details
11.9.2 Profectus BioSciences Inc Business Overview
11.9.3 Profectus BioSciences Inc Marburgvirus Infection Introduction
11.9.4 Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.9.5 Profectus BioSciences Inc Recent Development
11.10 Rodos BioTarget GmbH
11.10.1 Rodos BioTarget GmbH Company Details
11.10.2 Rodos BioTarget GmbH Business Overview
11.10.3 Rodos BioTarget GmbH Marburgvirus Infection Introduction
11.10.4 Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2016-2021)
11.10.5 Rodos BioTarget GmbH Recent Development
11.11 Sarepta Therapeutics Inc
11.11.1 Sarepta Therapeutics Inc Company Details
11.11.2 Sarepta Therapeutics Inc Business Overview
11.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Introduction
11.11.4 Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021)
11.11.5 Sarepta Therapeutics Inc Recent Development
11.12 Theravectys SA
11.12.1 Theravectys SA Company Details
11.12.2 Theravectys SA Business Overview
11.12.3 Theravectys SA Marburgvirus Infection Introduction
11.12.4 Theravectys SA Revenue in Marburgvirus Infection Business (2016-2021)
11.12.5 Theravectys SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Marburgvirus Infection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Eritoran Tetrasodium
Table 3. Key Players of AR-12
Table 4. Key Players of ARD-5
Table 5. Key Players of AVI-7288
Table 6. Key Players of Others
Table 7. Global Marburgvirus Infection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Marburgvirus Infection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Marburgvirus Infection Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Marburgvirus Infection Market Share by Regions (2016-2021)
Table 11. Global Marburgvirus Infection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Marburgvirus Infection Market Share by Regions (2022-2027)
Table 13. Marburgvirus Infection Market Trends
Table 14. Marburgvirus Infection Market Drivers
Table 15. Marburgvirus Infection Market Challenges
Table 16. Marburgvirus Infection Market Restraints
Table 17. Global Marburgvirus Infection Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Marburgvirus Infection Market Share by Players (2016-2021)
Table 19. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marburgvirus Infection as of 2020)
Table 20. Ranking of Global Top Marburgvirus Infection Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Marburgvirus Infection Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Marburgvirus Infection Product Solution and Service
Table 24. Date of Enter into Marburgvirus Infection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Marburgvirus Infection Revenue Market Share by Type (2016-2021)
Table 28. Global Marburgvirus Infection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Marburgvirus Infection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Marburgvirus Infection Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Marburgvirus Infection Revenue Market Share by Application (2016-2021)
Table 32. Global Marburgvirus Infection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Marburgvirus Infection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Marburgvirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Marburgvirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Marburgvirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Marburgvirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Marburgvirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Marburgvirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Marburgvirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Marburgvirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Marburgvirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Marburgvirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Marburgvirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Marburgvirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Marburgvirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Marburgvirus Infection Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Marburgvirus Infection Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Marburgvirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Marburgvirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Marburgvirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Marburgvirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Marburgvirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Marburgvirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Marburgvirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Marburgvirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Marburgvirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Marburgvirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Marburgvirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 64. Arno Therapeutics Inc Company Details
Table 65. Arno Therapeutics Inc Business Overview
Table 66. Arno Therapeutics Inc Marburgvirus Infection Product
Table 67. Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 68. Arno Therapeutics Inc Recent Development
Table 69. BioCryst Pharmaceuticals Inc Company Details
Table 70. BioCryst Pharmaceuticals Inc Business Overview
Table 71. BioCryst Pharmaceuticals Inc Marburgvirus Infection Product
Table 72. BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 73. BioCryst Pharmaceuticals Inc Recent Development
Table 74. Eisai Co Ltd Company Details
Table 75. Eisai Co Ltd Business Overview
Table 76. Eisai Co Ltd Marburgvirus Infection Product
Table 77. Eisai Co Ltd Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 78. Eisai Co Ltd Recent Development
Table 79. Emergent BioSolutions Inc Company Details
Table 80. Emergent BioSolutions Inc Business Overview
Table 81. Emergent BioSolutions Inc Marburgvirus Infection Product
Table 82. Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 83. Emergent BioSolutions Inc Recent Development
Table 84. Fab'entech SA Company Details
Table 85. Fab'entech SA Business Overview
Table 86. Fab'entech SA Marburgvirus Infection Product
Table 87. Fab'entech SA Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 88. Fab'entech SA Recent Development
Table 89. Integrated BioTherapeutics Inc Company Details
Table 90. Integrated BioTherapeutics Inc Business Overview
Table 91. Integrated BioTherapeutics Inc Marburgvirus Infection Product
Table 92. Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 93. Integrated BioTherapeutics Inc Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Marburgvirus Infection Product
Table 97. Johnson & Johnson Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. NanoViricides Inc Company Details
Table 100. NanoViricides Inc Business Overview
Table 101. NanoViricides Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 102. NanoViricides Inc Recent Development
Table 103. Profectus BioSciences Inc Company Details
Table 104. Profectus BioSciences Inc Business Overview
Table 105. Profectus BioSciences Inc Marburgvirus Infection Product
Table 106. Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 107. Profectus BioSciences Inc Recent Development
Table 108. Rodos BioTarget GmbH Company Details
Table 109. Rodos BioTarget GmbH Business Overview
Table 110. Rodos BioTarget GmbH Marburgvirus Infection Product
Table 111. Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 112. Rodos BioTarget GmbH Recent Development
Table 113. Sarepta Therapeutics Inc Company Details
Table 114. Sarepta Therapeutics Inc Business Overview
Table 115. Sarepta Therapeutics Inc Marburgvirus Infection Product
Table 116. Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 117. Sarepta Therapeutics Inc Recent Development
Table 118. Theravectys SA Company Details
Table 119. Theravectys SA Business Overview
Table 120. Theravectys SA Marburgvirus Infection Product
Table 121. Theravectys SA Revenue in Marburgvirus Infection Business (2016-2021) & (US$ Million)
Table 122. Theravectys SA Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Marburgvirus Infection Market Share by Type: 2020 VS 2027
Figure 2. Eritoran Tetrasodium Features
Figure 3. AR-12 Features
Figure 4. ARD-5 Features
Figure 5. AVI-7288 Features
Figure 6. Others Features
Figure 7. Global Marburgvirus Infection Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Marburgvirus Infection Report Years Considered
Figure 12. Global Marburgvirus Infection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Marburgvirus Infection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Marburgvirus Infection Market Share by Regions: 2020 VS 2027
Figure 15. Global Marburgvirus Infection Market Share by Regions (2022-2027)
Figure 16. Global Marburgvirus Infection Market Share by Players in 2020
Figure 17. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marburgvirus Infection as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Marburgvirus Infection Revenue in 2020
Figure 19. Global Marburgvirus Infection Revenue Market Share by Type (2016-2021)
Figure 20. Global Marburgvirus Infection Revenue Market Share by Type (2022-2027)
Figure 21. North America Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Marburgvirus Infection Market Share by Type (2016-2027)
Figure 23. North America Marburgvirus Infection Market Share by Application (2016-2027)
Figure 24. North America Marburgvirus Infection Market Share by Country (2016-2027)
Figure 25. United States Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Marburgvirus Infection Market Share by Type (2016-2027)
Figure 29. Europe Marburgvirus Infection Market Share by Application (2016-2027)
Figure 30. Europe Marburgvirus Infection Market Share by Country (2016-2027)
Figure 31. Germany Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Marburgvirus Infection Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Marburgvirus Infection Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Marburgvirus Infection Market Share by Region (2016-2027)
Figure 41. China Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Marburgvirus Infection Market Share by Type (2016-2027)
Figure 49. Latin America Marburgvirus Infection Market Share by Application (2016-2027)
Figure 50. Latin America Marburgvirus Infection Market Share by Country (2016-2027)
Figure 51. Mexico Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Marburgvirus Infection Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Marburgvirus Infection Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Marburgvirus Infection Market Share by Country (2016-2027)
Figure 57. Turkey Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Marburgvirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Arno Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 61. BioCryst Pharmaceuticals Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 62. Eisai Co Ltd Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 63. Emergent BioSolutions Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 64. Fab'entech SA Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 65. Integrated BioTherapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 67. NanoViricides Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 68. Profectus BioSciences Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 69. Rodos BioTarget GmbH Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 70. Sarepta Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 71. Theravectys SA Revenue Growth Rate in Marburgvirus Infection Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---